Molecular Insight Pharmaceuticals

Molecular Insight Pharmaceuticals

Pharmaceutical Manufacturing Cambridge, Massachusetts, United States 18 employees
Employees
18
Contacts
2
Emails
2
Phones
2

Molecular Insight Pharmaceuticals Overview

Headquarters
Cambridge, Massachusetts, United States
Industry
Pharmaceutical Manufacturing
Employees
18
Founded
1997
Company Email
Available in AeroLeads
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing

About Molecular Insight Pharmaceuticals

As of January 22, 2013, Molecular Insight Pharmaceuticals has been acquired by Progenics Pharmaceuticals. Molecular Insight Pharmaceuticals, Inc. develops therapeutic radiopharmaceuticals and molecular imaging agents for use in oncology and cardiology. The company targets the development of a small-molecule chemistry platform to improve detection of primary and metastatic prostate cancer and to provide a systemic radiotherapy for relapsed and metastatic prostate cancer. Its products include technetium Tc 99m trofolastat, a clinical-stage molecular imaging agent for patients with metastatic prostate cancer; and 131I-MIP-1095, a prostate cancer therapy for systemic delivery of radiotherapy.

Molecular Insight Pharmaceuticals Contact Details

People in AeroLeads
2
With contact data
2
Email contacts
2
100.0% coverage
Phone contacts
2
100.0% coverage

Molecular Insight Pharmaceuticals Org Chart

Sample employees and titles
Name Title Contact
James Wachholz Vice President Raqa at Molecular
Email Phone
Pete Manspeaker Owner, Vision Quest Bioscience, Llc
Email Phone

Compare Similar Companies to Molecular Insight Pharmaceuticals